69 Participants Needed

BREAST-Q REACT Tool for Breast Surgery

Recruiting at 5 trial locations
JN
AT
Overseen ByAudree Tadros, MD
Age: 18+
Sex: Female
Trial Phase: Academic
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

Do I need to stop my current medications for this trial?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the BREAST-Q REACT Tool treatment for breast surgery?

The BREAST-Q tool is widely recognized as a gold standard for measuring patient-reported outcomes in breast surgery, helping to ensure care is patient-centered and evidence-based. It has been effectively used to assess patient experiences and outcomes in breast reconstruction and other related procedures, indicating its utility in improving patient engagement and satisfaction.12345

What data supports the effectiveness of the BREAST-Q REACT Tool treatment for breast surgery?

The BREAST-Q is widely recognized as a gold-standard tool for collecting patient-reported outcomes in breast surgery, which helps improve patient-centered care by capturing patients' experiences and satisfaction. This tool has been effectively used in various studies to assess outcomes in breast reconstruction and surgery, indicating its utility in enhancing communication and engagement with patients.12345

Is the BREAST-Q REACT Tool safe for use in humans?

The available research does not provide specific safety data for the BREAST-Q REACT Tool, as it primarily focuses on its use as a patient-reported outcome measure in breast surgery.12467

Is the BREAST-Q REACT Tool safe for use in humans?

The available research does not provide specific safety data for the BREAST-Q REACT Tool, as it primarily focuses on its use as a patient-reported outcome measure in breast surgery.12467

How is the BREAST-Q REACT Tool treatment different from other treatments for breast surgery?

The BREAST-Q REACT Tool is unique because it focuses on collecting patient-reported outcomes (PROs) to enhance patient-centered care in breast surgery. Unlike traditional treatments, it emphasizes real-time engagement and communication to improve satisfaction and quality of life for patients undergoing breast surgery.14678

How is the BREAST-Q REACT Tool treatment different from other treatments for breast surgery?

The BREAST-Q REACT Tool is unique because it focuses on collecting patient-reported outcomes (PROs) to enhance patient-centered care in breast surgery, unlike traditional treatments that may not prioritize real-time patient feedback. This tool helps measure patient satisfaction and quality of life, providing valuable insights for personalized treatment decisions.14678

What is the purpose of this trial?

The researchers are doing this study to find out whether it is practical (feasible) to conduct a larger study looking at the effects of the BREAST-Q Real-time Engagement and Communication Tool (REACT) on people's quality of life, interactions with their doctors, and medical interventions after undergoing routine breast conserving surgery or mastectomy. The BREAST-Q REACT tool shows scores from standard questionnaires completed before and after breast surgery about overall physical wellbeing, arm pain or tightness, the ability to move the arms and perform everyday tasks, and any symptoms related to the arms, and provides feedback including recommendations and detailed information that help explain these scores and guide topics for people and their doctor to discuss.

Research Team

JN

Jonas Nelson, MD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Eligibility Criteria

This trial is for individuals undergoing routine breast conserving surgery or mastectomy. It aims to include those who are willing to use the BREAST-Q REACT tool, which involves completing questionnaires about their physical wellbeing and arm function before and after surgery.

Inclusion Criteria

Able to speak and understand English
I am female.
I am scheduled for breast surgery followed by reconstruction using implants or my own tissue.
See 2 more

Exclusion Criteria

I cannot communicate in English.
My breast cancer has come back.
I am male.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

up to 3 months

Treatment

Participants receive feedback using the BREAST-Q REACT tool and discuss it with their surgeon before and after routine breast surgery

up to 3 months

Follow-up

Participants are monitored for quality of life, interactions with doctors, and medical interventions after surgery

up to 3 months

Treatment Details

Interventions

  • BREAST-Q REACT Tool
Trial Overview The study is testing the BREAST-Q REACT tool's effectiveness in improving patients' quality of life, doctor-patient communication, and medical care post-surgery. Participants will provide feedback on physical well-being and arm mobility through standard questionnaires.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Intervention groupExperimental Treatment1 Intervention
Participants in the intervention group will receive feedback using the BREAST-Q REACT tool from questionnaires completed before and after routine surgery, in addition to the usual way by discussing it with their surgeon.
Group II: Control groupActive Control1 Intervention
Participants in the control group will receive the usual feedback from questionnaires completed before and after routine surgery by discussing it with their surgeon

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+

Findings from Research

The BREAST-Q tool has been increasingly utilized in breast surgery research, with 270 studies identified since 2015, highlighting its importance in measuring patient-reported outcomes and satisfaction.
Despite its growing use, there are still significant gaps in understanding the patient experience, indicating a need for more comprehensive data collection to enhance patient-centered care in breast surgery.
A Scoping Review of the Application of BREAST-Q in Surgical Research.Arora, N., Patel, R., Sohi, G., et al.[2023]
The BREAST-Q Implant Surveillance module (BREAST-Q IS) demonstrated good to excellent test-retest reliability among 207 breast implant recipients, indicating it is a reliable tool for assessing patient-reported outcomes in this population.
With a high response rate of 82% for breast augmentation and 94% for breast reconstruction, the study supports the use of BREAST-Q IS in registry settings, although further validation is needed to confirm its overall effectiveness as a patient-reported outcome measure.
Test-Retest Reliability of the BREAST-Q IS in the Australian Breast Device Registry.Merenda, M., Vishwanath, S., Ng, S., et al.[2021]
In a study of 88 patients undergoing implant-based breast reconstruction, significant improvements were reported in satisfaction with breast appearance and psychosocial well-being after surgery, as measured by the BREAST-Q survey.
Overall patient satisfaction with care was high, although physical well-being related to the chest did not show the same level of improvement, indicating areas for potential focus in post-operative care.
Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q data.Sala, L., Bonomi, S., Ciniselli, CM., et al.[2023]

References

A Scoping Review of the Application of BREAST-Q in Surgical Research. [2023]
Test-Retest Reliability of the BREAST-Q IS in the Australian Breast Device Registry. [2021]
Patient-reported outcome measurements in post-mastectomy implant-based breast reconstruction and radiotherapy: Analysis of BREAST-Q data. [2023]
Breast Cancer and Reconstruction: Normative Data for Interpreting the BREAST-Q. [2022]
Moving towards patient-reported outcomes in routine clinical practice: implementation lessons from the BREAST-Q. [2023]
Validation of the electronic version of the BREAST-Q in the army of women study. [2019]
The BREAST-Q: further validation in independent clinical samples. [2022]
Use of the BREAST-Q™ Survey in the Prospective Evaluation of Reduction Mammaplasty Outcomes. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security